ÂÜÀòÂÒÂ×

The Research and Development team at NEOGAP Therapeutics AB is dedicated to advancing the science behind personalized cancer treatments. This multidisciplinary team focuses on optimizing the production and characterization of tumor-trained lymphocytes, utilizing cutting-edge biochemistry, molecular biology, and bioinformatics. Through collaborative research efforts, they aim to refine therapeutic protocols and enhance the efficacy of immuno-oncology therapies, all while ensuring a highly customized approach for each patient.